Bellevue Life Sciences Ac...

NASDAQ: BLAC · Real-Time Price · USD
3.01
-3.72 (-55.27%)
At close: Feb 14, 2025, 3:53 PM

Bellevue Life Sciences Acquisition Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q4 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Dec 31, 2021
Cash & Equivalents
66.14K 12.24K 119.12K 3.64K 15.42K 57.95K 1.18K 348.8K 124.5K 68.83K 74.17K 4.76K
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
1.85M 20.89M 20.47M 37.21M 36.61M 72.05M 71.44M 70.63M n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a 1.1M 1.09M 984.99K 700.33K
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
389.26K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
455.4K 39.61K 166.83K 68.18K 22.63K 82.41K 58.98K 429.88K 124.5K 68.83K 74.17K 4.76K
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
1.85M 20.89M 20.47M 37.21M 36.61M 72.05M 71.44M 70.63M 1.1M 1.09M 984.99K 700.33K
Total Assets
2.3M 20.93M 20.63M 37.27M 36.63M 72.14M 71.49M 71.06M 1.23M 1.16M 1.06M 705.09K
Account Payables
n/a 1.26M 1.05M 1.55M n/a n/a 266.49K 386.43K 34K 20.7K 800.00 2.85K
Deferred Revenue
n/a n/a n/a -933.05K n/a -112.58K n/a n/a n/a n/a n/a -2.85K
Short-Term Debt
1.76M 1.78M 1.5M 135K n/a 200K n/a n/a 1.2M 900K 900K 400K
Other Current Liabilities
4.6M 1.88M 1.68M 2M 1.51M 517.35K 283.49K n/a n/a n/a n/a n/a
Total Current Liabilities
6.72M 3.94M 3.42M 2.75M 2.04M 1.11M 541.37K 403.43K 1.26M 1.19M 1.06M 707.21K
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
2.07M 2.07M 2.07M 2.07M 2.07M 2.07M 2.07M 2.07M n/a n/a n/a n/a
Total Long-Term Liabilities
2.07M 2.07M 2.07M 2.07M 2.07M 2.07M 2.07M 2.07M 1.23M n/a n/a n/a
Total Liabilities
8.79M 6.01M 5.49M 4.82M 4.11M 3.18M 2.61M 2.47M 1.26M 1.19M 1.06M 707.21K
Total Debt
1.76M 1.78M 1.5M 135K n/a 200K n/a n/a 1.2M 900K 900K 400K
Common Stock
1.85M 20.67M 20.05M 36.77M 36.43M 71.42M 70.98M 70.41M 173.00 173.00 173.00 173.00
Retained Earnings
-8.33M -5.75M -4.9M -4.31M -3.91M -2.46M -2.09M -1.83M -62.51K -48.26K -28.23K -27.12K
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity
-6.49M 14.91M 15.15M 32.46M 32.52M 68.96M 68.88M 68.58M -37.51K -23.26K -3.23K -2.12K
Total Investments
n/a 20.89M 20.47M 37.21M 36.61M 72.05M 71.44M 70.63M n/a n/a n/a n/a